Couverture de The Doctor Patient Forum

The Doctor Patient Forum

The Doctor Patient Forum

De : The Doctor Patient Forum
Écouter gratuitement

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
The Doctor Patient Forum is a national advocacy organization defending pain patients and the prescribers who treat them. We expose the truth about opioid policy, forced tapers, and patient abandonment. We expose the opioid elimination movement, and those at the center of it. Join Bev Schechtman and Claudia Merandi as we break down FDA moves, prescription surveillance systems like NarxCare, and the politics of addiction medicine. Because pain relief shouldn’t be a crime.The Doctor Patient Forum Economie Management Management et direction
Épisodes
  • The Opioid-Induced Hyperalgesia Hoax: How It Changed Pain Care and Harmed Patients - Episode 63
    Oct 20 2026
    For years, chronic pain patients have been told that the very medications relieving their pain may actually be making it worse. This claim, known as opioid-induced hyperalgesia (OIH), has been repeated by influential physicians, incorporated into clinical guidance, and added to FDA opioid labeling.But what does the evidence actually show?In this investigative presentation, The Doctor Patient Forum examines the science behind OIH, its origins in animal experiments, the limitations of human research, and how a disputed clinical theory became a justification for tapering, discontinuing, or denying opioid treatment.We examine:The history of OIH and the original animal experiments.What human studies actually demonstrate about chronic pain patients receiving long-term opioid therapy.The critical differences between OIH, tolerance, withdrawal, and disease progression.Statements from prominent physicians and researchers, including those who challenge the prevailing OIH narrative.How the FDA added OIH warnings to opioid medication labeling in 2023.Claims that buprenorphine (Suboxone) prevents or reverses OIH.How OIH has been used in clinical practice, insurance decisions, and arguments supporting opioid restrictions.The real-world experiences of patients who report losing access to pain treatment because of an OIH diagnosis or accusation.*When a medical theory influences federal policy and patient care, the evidence supporting it matters.*This presentation challenges the assumption that OIH is a well-established clinical explanation for worsening pain in patients receiving long-term opioid therapy and asks whether the available science justifies the ways this diagnosis has been used.*A note about the recording:* This investigation was originally recorded in 2025 and released exclusively to our Patreon community. For its public release, we updated the presentation with additional source clips and screenshots. Some references to dates and recent research reflect the original recording.*FULL CITATIONS AND SOURCES*Our complete citation page includes the scientific studies, FDA documents, presentations, and original sources for the clips featured in this investigation.Find the full citation page on our Patreon:patreon.com/thedoctorpatientforum https://www.thedoctorpatientforum.com*COPYRIGHT & FAIR USE NOTICE*This video contains excerpts of third-party videos, lectures, presentations, and other copyrighted materials used for criticism, commentary, analysis, research, and educational purposes.These excerpts are presented in the context of original commentary and analysis by The Doctor Patient Forum and are intended to constitute fair use under Section 107 of the U.S. Copyright Act (17 U.S.C. § 107).© The Doctor Patient Forum. Original commentary and presentation. All rights reserved.#OpioidInducedHyperalgesia #ChronicPain #PainPatients #OpioidPolicy #patientadvocacy OIH Video Chapters 00:00 Do Opioids Make Pain Worse?03:11 OIH vs. Tolerance and Withdrawal05:31 The Origins of OIH: From Rats to Humans11:28 What Does the Human Research Show?16:05 Dr. Norman Harden Challenges the OIH Theory21:49 How Experts Present OIH as Established Science29:30 How OIH Became a Powerful Narrative34:09 OIH in the Doctor's Office40:34 Dr. Dan Berland: Using OIH to Convince Patients44:17 Buprenorphine (Suboxone): The Supposed Solution51:34 How the OIH Narrative Expanded1:00:40 Defining and Diagnosing OIH1:03:39 The FDA's 2023 OIH Labeling Decision1:10:16 The Buprenorphine Double Standard1:13:36 Chronic Pain Patients Share Their Experiences1:16:41 Financial Incentives and Opioid Policy1:18:59 The 2025 Rat Study Challenges OIH1:22:49 What Needs to Change?1:25:52 What Doctors Say About OIH1:27:30 Final Thoughts1:29:04 Support DPF on Patreon
    Afficher plus Afficher moins
    1 h et 30 min
  • PROP Says Pain Patients Are Addicted. The FDA Data Tell a Different Story.
    Sep 10 2026
    Find us on Patreon.com/thedoctorpatientforumWhat happens when federally mandated opioid safety studies finally produce data that don’t fit the narrative we’ve been hearing for more than a decade?In this video, we break down the FDA’s May 5, 2025 opioid meeting, the Postmarketing Requirement studies that led to it, PROP’s influence over the conversation, and the fight over how chronic pain patients are diagnosed with opioid use disorder.At the center of this story is a staggering discrepancy: using raw DSM-5 criteria, 22.5% of patients in one of the FDA-mandated studies were classified as meeting criteria for OUD. But when researchers used a pain-adjusted diagnostic tool designed to distinguish addiction from behaviors explained by chronic pain and legitimate opioid therapy, that number dropped dramatically.Why was the pain-adjusted methodology attacked? Why were so many of the people speaking before the FDA affiliated with PROP or closely aligned with its policy positions? Why were paid opioid-litigation expert witnesses helping shape the discussion? And why has there been such a sustained effort to characterize patients taking prescription opioids exactly as directed as having opioid use disorder?We go back to the beginning: PROP’s 2012 FDA citizen petition, the 2013 FDA hearings, the 11 opioid Postmarketing Requirements ordered by the FDA, the development of pain-adjusted OUD measures, the May 2025 advisory committee meeting, the litigation relationships of prominent opioid-policy advocates, and the decades-long effort to move chronic pain patients away from full-agonist opioids.We also examine the history of buprenorphine/Suboxone, the push to expand treatment for OUD, and why redefining stable pain patients as having an addiction diagnosis has enormous consequences for medical care, insurance coverage, policy, and patient autonomy.This video was originally recorded in May 2025 as a Patreon-exclusive presentation. This public version was updated in 2026 with additional screenshots, court documents, source material, and supporting evidence uncovered after the original recording.The Doctor Patient Forum believes pain patients deserve more than slogans, cherry-picked statistics, and predetermined conclusions. If policymakers use science to justify taking treatment away, then they also have an obligation to measure what happens to the patients who lose that treatment.We are going to keep asking the questions.Support our work and access our Patreon-exclusive investigations, presentations, and member content: / thedoctorpatientforum Learn more about The Doctor Patient Forum:https://thedoctorpatientforum.com/Please like, subscribe, share, and leave a comment. Getting this information outside of the chronic pain community matters.*FAIR USE NOTICE*This video contains excerpts from publicly available hearings, presentations, news reports, court proceedings, documents, publications, screenshots, and other materials for purposes of commentary, criticism, education, research, news reporting, and public-interest discussion.Such use is intended to constitute fair use under Section 107 of the U.S. Copyright Act. Copyrighted materials remain the property of their respective owners. The Doctor Patient Forum does not claim ownership of third-party footage, images, documents, or other copyrighted material used in this presentation.#PainPatients #ChronicPain #FDA #Opioids #PROP #OpioidPolicy #OpioidUseDisorder #OUD #PatientAdvocacy #TheDoctorPatientForumHow this was made
    Afficher plus Afficher moins
    1 h et 17 min
  • Pain Patients Were Right: The “It’s All in Your Head” Narrative Is Falling Apart
    Jun 2 2026

    This episode was originally released as an exclusive Patreon video, but in the current climate, we believe it is too important to keep behind a paywall.

    Pain patients are increasingly being told their pain is “centralized,” “neuroplastic,” “psychological,” or simply “in the brain.” But what does that actually mean? And if a clinician claims someone’s physical pain is psychological, what diagnostic criteria are they using?

    In this conversation, Bev and Brandy speak with Asaf Weisman, a physiotherapist, researcher, PhD candidate, and lab manager at the Tel Aviv University Spinal Research Lab, about nociception, chronic pain, imaging, immune-system involvement, pain reprocessing claims, phantom limb pain, and the growing problem of dismissing patients when standard testing does not show a clear structural cause.

    Asaf explains why the absence of visible tissue damage on standard imaging does not prove the absence of a biological process, why pain cannot simply be labeled “psychological” without clear criteria, and why patients deserve better than gaslighting, abandonment, and one-size-fits-all narratives.

    Originally shared with our Patreon community. Released publicly because pain patients need to hear this.

    The Doctor Patient Forum:
    https://www.thedoctorpatientforum.com/

    Support our work on Patreon:
    https://patreon.com/thedoctorpatientforum

    Disclaimer: This episode is for education, commentary, and advocacy purposes only and is not medical advice. Please consult your own medical professional for care decisions.

    Afficher plus Afficher moins
    1 h et 24 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment